Register for our free email digests:
Division of AngioChem Inc.
Latest From Hutchison MediPharma Ltd.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
In a major show of force, four global pharma CEOs are heading to China to participate in high-level open and closed-door discussions that are expected to include a range of policy and regulatory reform topics. Tapping into China’s push to improve health and develop an innovation-driven economy may provide new openings for their voices to be heard.
The coming of spring has brought a flurry of senior executive moves at companies across Asia including WuXi, Fosun-Kite, Novartis, BGI and Chi-Med.
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
- Large Molecule
- Therapeutic Areas
- Metabolic Disorders
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- AngioChem Inc.
- Senior Management
Jean-Paul Castaigne, MD, Pres. & CEO
Betty Lawrence, VP, Dev.
Dejan Ristic, Acting Head, Fin.
Catherine Gagnon, Dir., Corp. Dev.
Jean E Lachowicz, PhD, CSO
- Contact Info
Phone: (514) 788-7800
201 President-Kennedy Ave.
Montreal, H2X 3Y7
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.